• 1. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 2. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 3. Achieving excellent anti-corrosion and tribological performance by tailoring the surface morphology and chemical composition of aluminum alloys
  Wenjie Zhao,Hua Hou,Yuchun Jin,Zhixiang Zeng,Xuedong Wu,Qunji Xue RSC Adv., 2014,4, 60307-60315
• 4. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 5. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277

Introduction to 4-Isoxazolecarboxylic Acid, 5-methyl-3-propyl- (CAS No. 17147-43-2)

4-Isoxazolecarboxylic Acid, 5-methyl-3-propyl- is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and chemical research due to its unique structural properties and potential biological activities. With a Chemical Abstracts Service (CAS) number of 17147-43-2, this compound represents a fascinating derivative of isoxazole, a heterocyclic structure known for its presence in various bioactive molecules. The presence of both methyl and propyl substituents at specific positions on the isoxazole ring introduces a level of complexity that makes it a valuable scaffold for medicinal chemistry investigations.

The isoxazole core is a six-membered aromatic ring containing an oxygen atom and a nitrogen atom at positions 1 and 3, respectively. This structural motif is widely recognized for its role in numerous pharmacologically active compounds, including antiviral, anti-inflammatory, and antimicrobial agents. The specific substitution pattern in 4-Isoxazolecarboxylic Acid, 5-methyl-3-propyl- not only enhances its solubility and metabolic stability but also influences its interactions with biological targets. Such modifications are crucial in drug design, as they can significantly alter the compound's pharmacokinetic profile and therapeutic efficacy.

In recent years, there has been growing interest in exploring the pharmacological potential of isoxazole derivatives. The combination of the 5-methyl and 3-propyl groups in this compound may contribute to its ability to modulate various biological pathways. For instance, studies have suggested that isoxazole derivatives can interact with enzymes and receptors involved in pain signaling, inflammation, and neurodegeneration. The carboxylic acid moiety at the fourth position further extends the possibilities for chemical modifications, allowing for the synthesis of prodrugs or conjugates that could improve bioavailability or target specificity.

One of the most compelling aspects of 4-Isoxazolecarboxylic Acid, 5-methyl-3-propyl- is its versatility as a building block in synthetic chemistry. Researchers have leveraged this compound to develop novel analogs with enhanced biological activity. For example, recent studies have demonstrated that derivatives of this molecule exhibit promising effects on enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), which are key players in inflammatory processes. The structural features of this compound make it an attractive candidate for further investigation into potential therapeutic applications.

The synthesis of 4-Isoxazolecarboxylic Acid, 5-methyl-3-propyl- involves multi-step organic reactions that require precise control over reaction conditions. The introduction of the 5-methyl group at the fifth position and the 3-propyl group at the third position demands careful selection of reagents and catalysts to ensure high yield and purity. Advances in synthetic methodologies have made it possible to produce this compound with increasing efficiency, enabling more extensive exploration of its chemical space.

From a computational chemistry perspective, molecular modeling studies have been instrumental in understanding the binding interactions of 4-Isoxazolecarboxylic Acid, 5-methyl-3-propyl- with biological targets. These simulations have helped researchers predict potential drug candidates and optimize their structures for better efficacy. The integration of machine learning algorithms has further accelerated this process by enabling rapid screening of large libraries of compounds based on their predicted binding affinities.

The biological activity of this compound has been evaluated through various in vitro assays. Initial studies have shown that it exhibits moderate inhibitory effects on certain enzymes associated with inflammatory diseases. While these findings are promising, further research is needed to fully elucidate its mechanism of action and therapeutic potential. Preclinical studies are underway to assess its safety profile and pharmacokinetic properties in animal models.

The pharmaceutical industry has taken note of the potential applications of isoxazole derivatives like 4-Isoxazolecarboxylic Acid, 5-methyl-3-propyl-. Several companies are investing in research programs aimed at developing novel drugs based on this scaffold. The unique combination of structural features makes it an attractive candidate for further development into treatments for conditions such as arthritis, asthma, and neurodegenerative disorders.

In conclusion,4-Isoxazolecarboxylic Acid, 5-methyl-3-propyl- (CAS No. 17147-43-2) represents a significant advancement in medicinal chemistry due to its complex structure and promising biological activities. Its role as a versatile scaffold for drug discovery underscores its importance in ongoing research efforts aimed at developing new therapeutic agents. As scientific understanding continues to evolve, it is likely that this compound will play an increasingly important role in addressing unmet medical needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)